Dr. Markman Discusses Concept of Precision Medicine in Gynecologic Cancers
January 23rd 2019Maurie Markman, MD, president of Medicine and Science, Cancer Treatment Centers of America, editor-in-chief, OncologyLive, and 2018 Giant of Cancer Care for Gynecological Cancers, discusses the concept of precision medicine in gynecologic cancers.
Read More
Dr. Markman on Cost Effectiveness of Precision Medicine in Gynecologic Cancers
January 15th 2019Maurie Markman, MD, president of Medicine and Science, Cancer Treatment Centers of America, editor-in-chief, OncologyLive, and 2018 Giant of Cancer Care for Gynecological Cancers, discusses the cost effectiveness of precision medicine in gynecologic cancers.
Read More
Dr. Markman on Unmet Needs in Endometrial and Cervical Cancers
January 9th 2019Maurie Markman, MD, president of Medicine and Science, Cancer Treatment Centers of America, editor-in-chief, OncologyLive, and 2018 Giant of Cancer Care for Gynecological Cancers, discusses unmet needs in endometrial and cervical cancers.
Read More
Dr. Markman Discusses Treating Ovarian Cancer as Chronic Disease
January 4th 2019Maurie Markman, MD, president of Medicine and Science, Cancer Treatment Centers of America, editor-in-chief, OncologyLive, and 2018 Giant of Cancer Care for Gynecological Cancers, discusses the treatment of ovarian cancer as a chronic disease.
Read More
New Strategies Are Needed as Ovarian Cancer Becomes a Chronic Disease
December 10th 2018Since the introduction of platinum agents in ovarian cancer, it is reasonable to suggest there have been only limited changes in the basic paradigm of ovarian cancer management over the past several decades.
Read More
Dr. Markman on Precision Medicine in Ovarian Cancer
November 30th 2018Maurie Markman, MD, president of Medicine and Science, Cancer Treatment Centers of America, editor-in-chief, OncologyLive, and 2018 Giant of Cancer Care for Gynecological Cancers, discusses the impact of precision medicine in ovarian cancer.
Read More
Dr. Markman on the Concept of Biosimilars in Oncology
November 27th 2018Maurie Markman, MD, president of Medicine and Science, Cancer Treatment Centers of America, editor-in-chief, OncologyLive, and 2018 Giant of Cancer Care® for Gynecological Cancers, discusses the concept of biosimilars in oncology.
Read More
Dr. Markman Discusses the Future of Treatment for Ovarian Cancer
November 15th 2018Maurie Markman, MD, president of Medicine and Science, Cancer Treatment Centers of America, editor-in-chief, OncologyLive, and 2018 Giant of Cancer Care® for Gynecological Cancers, discusses the future of treatment for patients with ovarian cancer.
Read More
Right-to-Try Laws: Let's Move Beyond the Rhetoric
May 15th 2018Maurie Markman, MD, shares his thoughts on the right-to-try bill, which would allow terminally ill patients to receive investigational drugs that have been studied in phase I trials without applying through the FDA’s expanded access program.
Read More
All Is Not Well in the World of Academic Scientific Enterprise
April 28th 2018It is quite difficult for those not directly involved in the complex world of academic medicine to understand fully the process of individual professional advancement and the values that organizations place on the components required for achieving and maintaining tenure.
Read More
HPV Vaccination Should Be Part of Oncology Cost-Reduction Strategy
April 3rd 2018The impact of staggering increases in the cost of individual antineoplastic agents for patients and the overall healthcare system cannot be overstated, and there appears to be no realistic solution to the current dilemma that is acceptable to the parties involved in this ongoing debate.
Read More